The number of people with susceptibility test result for rifampicin in Vanuatu
Vanuatu: The number of people with susceptibility test result for rifampicin was 0 in 2021. ◆ Volatile
Latest (2021)
0
Change on year
down 100.0%
World rank
142nd
of 146 countries
All-time high
100
in 2018
All-time low
0
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Vanuatu, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Vanuatu is 0, measured in 2021. That is the lowest value across all 5 years on record.
The figure is down 100.0% on the previous year and down 100.0% over five years.
That places Vanuatu 142nd out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Vanuatu, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 97.87 | — |
| 2018 | 100 | +2.2% |
| 2019 | 100 | +0.0% |
| 2020 | 93.48 | -6.5% |
| 2021 | 0 | -100.0% |
Vanuatu compared with similar countries
- Vanuatu's 0 is below the median for lower middle income countries, which is 78.77. (32 countries reporting)
- Vanuatu's 0 is below the median for East Asia & Pacific, which is 96.47. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 99.29 | 97.87 | 100 | 3 |
| 2020s | 46.74 | 0 | 93.48 | 2 |
Countries ranked near Vanuatu
- 139 Central African Republic 9.75 compare
- 140 Venezuela, Bolivarian Republic of 3.31 compare
- 141 France 1.45 compare
- 142 South Sudan 0 compare
- 142 Grenada 0 compare
- 142 Sao Tome and Principe 0 compare
- 142 Mauritania 0 compare
More health data for Vanuatu
- Un projection of annual infant deaths, annual growth rate -2.22 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8846 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 695.7 deaths per 1,000 people (2090)
- Number of infants who die before age 1 44 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.3888 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0639 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.395 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Vanuatu?
- The number of people with susceptibility test result for rifampicin in Vanuatu was 0 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Vanuatu?
- The highest recorded value was 100 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Vanuatu?
- The lowest recorded value was 0 in 2021.
- How does Vanuatu rank for the number of people with susceptibility test result for rifampicin?
- Vanuatu ranks 142nd out of 146 countries with data for 2021.
- Where does this Vanuatu data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).